Biosimilar Manufacturing solution center
-
Environmental Monitoring Performance Qualification In New Drug Manufacturing Facilities
8/1/2025
In setting up a new manufacturing facility, a robust process for environmental monitoring must be established and cleanrooms in the classified areas must be properly qualified. Here are critical considerations to keep in mind.
-
Balancing Protein A Resin Cost, Performance, And Productivity
7/31/2025
Optimizing input parameters like DBC, flow rate, and resin durability is key to boosting productivity in downstream bioprocessing. Discover how to tailor resin choices to meet your specific process requirements.
-
AI Data Security: The 83% Compliance Gap Facing Pharmaceutical Companies
7/23/2025
A new study reveals a shocking truth: only 17% of pharmaceutical companies — including many CDMOs — have implemented automated controls to prevent sensitive data from leaking through AI tools.
-
Here's What Limits AI's Outlook For Replacing Knowledge Workers
7/21/2025
Even after AI developers clean up hallucinations and other short-term issues, a large-scale workforce replacement faces a few intractable obstacles.
-
How Much Knowledge Work Can Biopharma Offload To AI? Answer: Not Much
7/21/2025
In biomanufacturing, knowledge work and manual work are deeply intertwined. One expert suggests replacing entire workflows with artificial intelligence seems unlikely.
-
Non Animal Origin Squalene For High-Risk Applications
7/21/2025
Explore an ethical and sustainable alternative to shark-derived squalene that is backed by robust data to deliver identical performance in vaccine formulations without environmental compromise.
-
Pharma Enterprise Resource Planning: From Automation To AI-Driven Insights
7/10/2025
Pharmaceutical firms are increasingly turning to enterprise resource planning (ERP) systems to modernize operations. These platforms unify core functions, including supply chain management, manufacturing, and financial planning and analysis.
-
Managing Extractables And Leachables In HPAPI Manufacturing
7/10/2025
These contaminants can compromise the quality, stability, and safety of a drug product, and regulatory bodies mandate assessment to protect patients.
-
Unlocking Value In Biopharma Operations: A C-Suite Call To Action
7/9/2025
Operational readiness will separate the leaders from the laggards, whether you lead a pharma/biotech innovator, CDMO, or a combination of both.
-
Audit Trail Compliance And What To Look For In Mitigation Software
7/9/2025
In the pharma/biotech and medical device industries, the audit trail is important to have for accountability, data integrity, repeatability to create an event for investigation, and regulatory compliance.